Pricing Log in Create free account

Affimed N.V. (AFMDQ) vs Decoy Therapeutics Inc (DCOY)

Affimed N.V. and Decoy Therapeutics Inc are both Biotechnology companies. Affimed N.V. and Decoy Therapeutics Inc are of similar size ($2.8M and $2.7M). Decoy Therapeutics Inc grew revenue faster over the last twelve months: −60.5% against −95.2%. Decoy Therapeutics Inc has the higher net margin (−698.8% vs −7,834.6%) and the higher return on invested capital (0.00% vs −13,558.8%). Across the 17 metrics below, Affimed N.V. leads on 9 and Decoy Therapeutics Inc on 8.

Valuation

Metric AFMDQ DCOY Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.29 9.40
P/B n/m 0.14 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.26 0.49 0.66
EV/Sales (19.16) (3.49) 9.02
Earnings yield 0.00% (5,122.62%) (32.88%)
Free cash flow yield 0.00% (1,736.93%) (23.13%)

Profitability

Metric AFMDQ DCOY Biotechnology median
Gross margin 100.00% 10.57% 68.51%
Operating margin (7,858.63%) (706.88%) 0.00%
Net margin (7,834.59%) (698.79%) 0.00%
Free cash flow margin (8,603.91%) (432.43%) 0.00%
Return on equity (148.64%) (827.77%) (51.96%)
Return on assets (86.68%) (278.04%) (46.06%)
Return on invested capital (13,558.83%) 0.00% 0.00%

Growth

Metric AFMDQ DCOY Biotechnology median
Revenue growth (TTM) (95.23%) (60.49%) 6.76%
EPS growth (last fiscal year) (21.75%) 87.62% 29.88%
Revenue growth, 5-year CAGR (20.40%) 12.73% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AFMDQ DCOY Biotechnology median
Debt to equity 0.47 0.00 0.00
Current ratio 1.93 1.83 4.97
Net debt to EBITDA 0.58 0.85 1.01

Dividend

Metric AFMDQ DCOY Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AFMDQ DCOY Biotechnology median
Market cap 2.76m 2.67m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack